Sepsis Clinical Trial
Official title:
Comparison of Non-Invasive Methods of Assessing Fluid Responsiveness in ED and ICU Patients
Accurate assessment of fluid responsiveness (FRes) is central to guiding fluid management in
septic and critically ill patients. As evidence accumulates that both inadequate and
excessive fluid resuscitation are associated with increased morbidity and mortality, it is
simultaneously becoming increasingly clear that current widely used methods to predict FRes
are of questionable accuracy. The optimal technique to predict FRes would be a non-invasive
point-of-care test with not only a high degree of accuracy, but also one which requires
minimal training to perform correctly and may be easily performed repeatedly for serial
evaluation of FRes during the ongoing management of the critically ill patient.
To date, three major ultrasonographic modalities have emerged as viable candidates for the
bedside assessment of FRes: 1) measurement of dynamic changes in inferior vena caval diameter
(IVC-CI), 2) measurement of dynamic changes in peripheral arterial waveform derived variables
(PA Doppler), and 3) echocardiographic measurement of dynamic changes in left ventricular
outflow tract waveform derived variables (LVOT Doppler). In this study, the investigators
will perform the first direct comparison of techniques representing all three of the above
modalities in the prediction of FRes against a non-invasive bioreactance cardiac output
monitor (the Cheetah NICOM™), which has been extensively validated against gold-standard
invasive methods of cardiac output measurement. The investigators will compare the accuracy
of these modalities in both spontaneously breathing and mechanically ventilated patients
using passive leg raise testing (PLR) as a surrogate for volume challenge. In addition, the
investigators will also elicit information from the treating physician(s) on their clinical
assessment of FRes.
The investigators will recruit adult patients in the ED and ICU with sepsis, who have
received an initial bolus of 20-30 cc/kg of IV fluid, and can tolerate the PLR and US
procedures. Prior to US and NICOM measurement, investigators will ask the attending physician
managing the patient regarding their assessment of the their fluid status. Then, separate
investigators will perform US and NICOM measurements independently to ensure blinding. NICOM
data, which has been well validated in septic patients, will be shared with the attending
physician. They will then be asked if this new data will change management.
This is a diagnostic accuracy study comparing selected ultrasound techniques to a well
validated standard for predicting fluid responsiveness in septic patients (NICOM). The
primary outcomes will be reported in sensitivity, specificity, positive predictive value,
negative predictive value, likelihood ratios, and receiver operating characteristic curves.
The timeframe for measurement is within 72 hours of the subjects' admission. Determination of
the outcome (i.e., whether a subject is fluid responsive) is based upon the data generated by
the NICOM device. The NICOM generates data within 5 minutes of assessment. The ultrasound
modalities to be studied will generate data within 5 minutes of assessment as well. The US
data will be compared to the NICOM data to generate the statistics listed in this protocol.
There is no further planned follow-up for the subjects.
1. The investigators will compare the ability of dynamic changes in inferior vena caval
diameter (IVC-CI), dynamic changes in peripheral arterial waveform derived variables (PA
Doppler), and dynamic changes in left ventricular outflow tract waveform derived
variables (LVOT Doppler) to detect fluid responsiveness (FRes) relative to FRes as
assessed by bioreactance cardiac output monitoring before and after passive leg raise
(PLR).
Hypothesis: PA Doppler and LVOT Doppler will have superior sensitivity and specificity
to predict FRes in comparison to IVC-CI.
2. The investigators will evaluate data acquisition duration and data acquisition failure
rate of IVC-CI, PA Doppler, and LVOT Doppler. Hypothesis: PA Doppler will have shorter
data acquisition durations in comparison to LVOT velocity variation and IVC-CI.
Hypothesis: PA Doppler will have lower data acquisition failure rates in comparison to
LVOT velocity variation and IVC-CI.
3. The investigators will compare the ability of IVC-CI, PA Doppler, and LVOT Doppler to
predict FRes in comparison to FRes as predicted by clinical judgment.
Hypothesis: PA Doppler and LVOT Doppler will have superior sensitivity and specificity
to predict FRes in comparison to clinical judgment.
4. The investigators will evaluate the ability of dynamic changes in PA corrected flow
times (cFT) to detect FRes relative to FRes as assessed by bioreactance cardiac output
monitoring before and after PLR. Hypothesis: cFT will have greatest sensitivity and
specificity to predict FRes at a Δflow time threshold of ≥15% after PLR.
Hypothesis: At a Δflow time threshold of ≥15%, cFT will have superior sensitivity and
specificity to detect FRes in comparison to IVC-CI.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |